Business

‘I didn’t know what else to do:’ Patients take their health-insurance battles to Facebook and LinkedIn

MarketWatch · August 13, 2026 at 5:14 PM

‘I didn’t know what else to do:’ Patients take their health-insurance battles to Facebook and LinkedIn

It took Payton Herres going viral — twice — to get her health insurer to cover a lifesaving medication.

The 26-year-old, who underwent a heart transplant in 2012, began taking an off-label prescription for everolimus, a generic version of Novartis’s anti-rejection drug Zortress, a year later.

Read the full article on MarketWatch ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.

This story in other outlets

What I Saw In Sinaloa

The Atlantic · 5 h ago

‘I didn’t know what else to do:’ Patients take their health-insurance battles to Facebook and LinkedIn

This story in other outlets

What I Saw In Sinaloa

More from MarketWatch

Dell’s stock has beaten Micron and AMD this year — and now it’s adding to its gains

Salesforce’s stock gets a boost as J.P. Morgan says AI fears are overblown

Sandisk’s stock is flying higher. Here are the new targets that are exciting Wall Street.

Markets are looking eerily calm as investors chase FOMO rally

More in Business

Russell Westbrook’s NBA Triple-Double Record May Not Last Long

Dell’s stock has beaten Micron and AMD this year — and now it’s adding to its gains

Salesforce’s stock gets a boost as J.P. Morgan says AI fears are overblown

Sandisk’s stock is flying higher. Here are the new targets that are exciting Wall Street.

Markets are looking eerily calm as investors chase FOMO rally

‘It feels like a medical miracle’: How did a single QR code coupon cut my $618 Walgreens prescription to $15?